Age at year of index date, % |
22-44 years |
2.4% |
5.5% |
<0.0001 |
45-54 years |
7.9% |
7.9% |
55-64 years |
14.8% |
12.0% |
65-74 years |
45.3% |
37.8% |
>75 years |
29.6% |
36.8% |
Sex, % |
Men |
51.3% |
46.2% |
<0.0001 |
Index diagnosis, % |
AMI |
21.1% |
11.9% |
<0.0001 |
Unstable angina |
11.4% |
5.9% |
<0.0001 |
Hemorrhage |
1.3% |
2.1% |
<0.0001 |
Stroke |
28.8% |
27.6% |
<0.0001 |
Transient cerebral ischemia |
10.6% |
10.4% |
0.0558 |
Cerebrovascular disease |
11.7% |
16.4% |
<0.0001 |
Atherosclerosis |
7.4% |
8.7% |
<0.0001 |
Peripheral vascular disease |
25.6% |
32.0% |
<0.0001 |
Arterial embolism |
0.5% |
0.4% |
0.0438 |
Arterial disorder |
0.9% |
0.9% |
0.3029 |
CABG |
3.2% |
0.5% |
<0.0001 |
Coronary angioplasty |
9.8% |
2.0% |
<0.0001 |
Revascularization surgery |
0.03% |
0.01% |
<0.0001 |
Peripheral bypass |
0.16% |
0.17% |
0.3844 |
Race, % |
White |
70.0% |
68.9% |
<0.0001 |
Black |
10.4% |
9.2% |
Asian |
0.5% |
0.4% |
Hispanic |
1.8% |
1.3% |
Unknown |
17.4% |
20.2% |
Region, % |
Midwest |
23.5% |
29.1% |
<0.0001 |
Northeast |
1.8% |
2.3% |
South |
64.5% |
59.2% |
West |
9.1% |
8.7% |
Unknown |
1.2% |
0.7% |
Health plan, % |
Medicare |
85.8% |
83.5% |
<0.0001 |
Medicaid |
0.4% |
0.4% |
HMO |
3.8% |
4.0% |
POS |
2.8% |
3.1% |
PPO |
5.7% |
5.6% |
Other plan |
1.6% |
3.4% |
Prior utilization (6 months) |
Hospital admission, % |
10.1% |
12.9% |
<0.0001 |
Medical costs, US $, mean (SD) |
1864 (4253) |
2257 (5491) |
<0.0001 |
Inpatient costs, US $, mean (SD) |
1408 (8084) |
2170 (12 457) |
<0.0001 |
Pharmacy costs, US $, mean (SD) |
667 (1477) |
651 (1898) |
0.0326 |
Total costs, US $, mean (SD) |
3939 (10 202) |
5079 (14 754) |
<0.0001 |
LDL values at baseline in subgroup (n=49 224) |
Newly eligible secondary prevention patients |
n=14 381 |
n=34 843 |
|
<101 mg/dL |
30.6% |
45.3% |
<0.0001 |
101-130 mg/dL |
34.5% |
35.3% |
ATP III eligible secondary prevention patients |
|
|
131-160 mg/dL |
23.8% |
14.8% |
>160 mg/dL |
11.1% |
4.6% |